In this episode of the Diagnosing Health Care Podcast Renewed interest in the potential benefits of psychedelic treatments has led to an upsurge in research. Is the first FDA approval of a psychedelic for therapeutic use on the horizon?

On this episode, Epstein Becker Green attorneys Delia Deschaine, Lisa Gora, and Jessika Tuazon examine the history of psychedelic substances in the United States and discuss the evolving legal and regulatory considerations impacting the development, approval, distribution, and use of psychedelic therapies in the United States.

* * *

The Diagnosing Health Care podcast series examines the business opportunities and solutions that exist despite the high-stakes legal, policy, and regulatory issues that the health care industry faces.

Subscribe on your favorite podcast platform: Amazon Music / AudibleApple Podcasts, AudacyDeezerGoogle Podcasts, iHeartRadio, Overcast, PlayerFM, Spotify, Stitcher, Vimeo, YouTube – and sign up for email notifications.